The Model for End-Stage Liver Disease (MELD) can be used to evaluate short term survival in an adult with end-stage liver disease. This can help stratify candidates for liver transplantation. The original authors are from the Mayo Clinic, Beth Israel Deaconess Medical Center, University of Minnesota and Rotterdam University Hospital.

To read more or access our algorithms and calculators, please log in or register.